Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by Lenacapavir
Clinical Effects
Potential for increased alfuzosin effects
Management
Consider alternative to alfuzosin. If coadministered, monitor for adverse effects (e.g. hypotension)
Info Source
